-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Amylyx Pharmaceuticals, Inc. annual/quarterly Revenues history and growth rate from Q3 2021 to Q3 2022.
- Amylyx Pharmaceuticals, Inc. Revenues for the quarter ending September 30, 2022 was $345K, a 21.1% increase year-over-year.
- Amylyx Pharmaceuticals, Inc. annual Revenues for 2023 was $381K, a 98.3% decline from 2022.
- Amylyx Pharmaceuticals, Inc. annual Revenues for 2022 was $22.2M, a 7700% increase from 2021.